Hormone replacement therapy improves sleep, sexuality and joint pain in older womenAugust 22, 2008Results of new quality of life study revealed One of the world's longest and largest trials of hormone replacement therapy (HRT) has found that post-menopausal women on HRT gain significant improvements in quality of life. The results of the latest study by the WISDOM research team (Women's International Study of long Duration Oestrogen after Menopause) are published today on the British Medical Journal website www.bmj.com.
The study involved 2130 post-menopausal women in the UK, Australia and New Zealand, and assessed the impact of combined oestrogen and progestogen hormone therapy on the women's quality of life. The average age of women in this study was 13 years after menopause and most participants did not have menopausal symptoms. "Our results show that hot flushes, night sweats, sleeplessness and joint pains were less common in women on HRT in this age group. Sexuality was also improved," says Professor Alastair MacLennan, leader of the Australian arm of WISDOM and head of Obstetrics & Gynaecology at the University of Adelaide, Australia. "Overall, quality of life measures improved. Even when women did not have hot flushes and were well past menopause, there was a small but measurable improvement in quality of life and a noted improvement in sleep, sexuality and joint pains. HRT users also had more breast tenderness and discharge compared to those on a placebo," he says. Dr Beverley Lawton, Head of WISDOM New Zealand, says: "These new data should be added to the risk/benefit equation for HRT. The quality of life benefits of HRT may be greater in women with more severe symptoms near menopause. New research suggests that HRT taken from near menopause avoids the cardiovascular risks seen when HRT is initiated many years after menopause." Professor MacLennan says studies such as those conducted by WISDOM "enable the risks of HRT to be reduced and its benefits maximized when the treatment is individualized to each woman". "Early start-up side effects can usually be alleviated by adjusting the treatment," he says. "For most women with significant menopause symptoms the benefits of HRT outweigh the risks. The latest analyses of the main long-term randomized control trial of HRT (The Women's Health Initiative) show that breast cancer is not increased by oestrogen-only HRT and is only increased in women using combined oestrogen and progestogen HRT after seven years of use. This increased risk is less than 0.1% per year of use. "If a woman feels that HRT is needed for quality of life, then doctors can find the safest regimen for her. She can try going off HRT every 4-5 years, and can then make an informed choice about whether she takes and continues HRT." University of Adelaide Science News and Science Current Events Tag Cloud This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size. Polio Magnetic resonance imaging Aneurysm Tumor Periodontitis Quantum computer Dengue Human Papillomavirus Sharks Saliva Binge Drinking Wireless Sudden Infant Death Syndrome Magnetic Field Cancer Gene Metabolic Syndrome Lupus CO2 emissions Upper Atmosphere Stem Cell Wetlands Antibiotics HIV infection Colorectal Cancer Tropical Disease
See More: Science News Tags | |||||||||||||||||||||
|
Related Hormone Replacement Therapy Current Events and Hormone Replacement Therapy News Articles Dr. Ronald Lewis Couples' treatment for sexual problems on the agenda for sexual medicine experts Couples' treatment for sexual problems and other innovative approaches to improving sexual health for men and women are on the agenda of sexual medicine experts. Hormone therapy plus physical activity reduce belly fat, body fat percentage after menopause Older women who take hormone therapy to relieve menopausal symptoms may get the added benefit of reduced body fat if they are physically active, according to a new study. Defeating nicotine's double role in lung cancer A lung cancer treatment that inhibits nicotine receptors was shown to double survival time in mice, according to Italian researchers. HRT-breast cancer risk stays same, regardless of family history The risk of developing breast cancer due to taking hormone replacement therapy appears to be the same for women with a family history of the disease and without a family history. Yerkes Researchers Use Eye Tracking to Detect Mild Dementia In Humans Researchers at the Yerkes National Primate Research Center, Emory University, developed a test in nonhuman primates that is now using infrared eye tracking to detect mild cognitive impairment (MCI) in humans. Study identifies potential 'safe period' for hormone replacement use A new study makes important new findings on the role of hormone use on the risk of breast cancer, confirming that the use of estrogen plus progesterone increases the risk of both ductal and lobular breast cancer far more than estrogen-only; suggesting a two-year "safe" period for the use of estrogen and progesterone; and finding that the increased risk for ductal cancers observed in long-term past users of hormone replacement therapy drops off substantially two years after hormone use is stopped. Breast Cancer Drug Shows Promise for Treating, Preventing Progestin-Dependent Tumors Recent studies suggest that human breast cancer risk is increased by outside exposure to the hormone progestin, such as during hormone replacement therapy. Now, a University of Missouri study suggests that PRIMA-1, a small molecule drug that targets the most common mutated gene, p53, in human cancer cells, has potential as a novel chemotherapeutic treatment for progestin-accelerated human breast cancer. Is rapid transition through menopause linked to earlier onset of heart disease? An evaluation of 203 women as part of the multifaceted Los Angeles Atherosclerosis Study (LAAS) found that those who transitioned more quickly through menopause were at increased risk for a higher rate of progression of "preclinical atherosclerosis" - narrowing of arteries caused by the thickening of their walls. Contraceptive use may be safe, but information gaps remain Introduced in the 1960s, oral contraceptives have been used by about 80 percent of women in the United States at some point in their lives. New mammography technology effective in detecting breast cancer A study has found that positron emission mammography (PEM), a new technique for imaging the breast, is not affected by either breast density or a woman's hormonal status, two factors that limit the effectiveness of standard mammography and MRI at detecting cancer. More Hormone Replacement Therapy Current Events and Hormone Replacement Therapy News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||